Pharmaceutical intermediates
Ruxolitinib phosphate Intermediates
18 pharmaceutical intermediates for Ruxolitinib phosphate. Indication: Graft-Versus-Host Disease (GVHD); Vitiligo; Atopic Dermatitis; Myelofibrosis; Polycythemia Vera.
About Ruxolitinib phosphate
- Originator
- Incyte Corp
- Indication
- Graft-Versus-Host Disease (GVHD); Vitiligo; Atopic Dermatitis; Myelofibrosis; Polycythemia Vera
- Approved Date
- 12/01/2011
- DS/DP
- 12/24/2027
Available intermediates
18 intermediates currently listed for Ruxolitinib phosphate. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| 1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | 1029716-44-6 | / | / |
| -CYCLOPENTYLACRYLONITRILE | 591769-05-0 | / | / |
| Cyclopentanecarbaldehyde | 872-53-7 | / | / |
| 4-Chloropyrrolo[2,3-d]pyrimidine | 3680-69-1 | / | / |
| 4-(1H-pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine | 941685-27-4 | / | / |
| 3-cyclopentyl-3-[4-(7-[2-(trimethylsilyl)ethoxy]methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile | 941685-39-8 | / | / |
| (3R)-3-cyclopentyl-3-[4-(7-[2-(trimethylsilyl)ethoxy]methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile | 941685-40-1 | / | / |
| (S)-3-cyclopentyl-3-hydrazinylpropanenitrile L-tartaric acid salt dihydrate | 2761879-36-9 | / | / |
| 2-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)acetic acid | 1000518-93-3 | / | / |
| 4-methyl-7H-pyrrolo[2,3-d]pyrimidine | 945950-37-8 | / | / |
| (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile | 41678-49-5 | / | / |
| (4-(1-(2-Cyano-1-cyclopentylethyl)-1h-pyrazol-4-yl)-7h-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate | 1236033-05-8 | / | / |
| 4-CHLORO-7-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-7H-PYRROLO[2,3-D]PYRIMIDINE | 941685-26-3 | / | / |
| 1H-Pyrazole-1-propanamide, 4-bromo-β-cyclopentyl-, (βR)- | 2201066-06-8 | / | / |
| (R)-3-(4-broMo-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile | 1146629-83-5 | / | / |
| (R)-3-cyclopentyl-3-(4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanenitrile | 1146629-84-6 | / | / |
| 3-Cyclopentyl-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]propanenitrile | 1153949-38-2 | / | / |
| (4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate | 1146629-75-5 | / | / |
Other programs under R
Building toward Ruxolitinib phosphate?
Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →